dimethyl fumarate polpharma
zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetylfumarát - roztrúsená skleróza, recidivujúce-odosielajúcej - imunosupresíva - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
dimtruzic 240 mg
sandoz pharmaceuticals d.d., slovinsko - dimetyl-fumarát - 59 - immunopraeparata
dimtruzic 120 mg
sandoz pharmaceuticals d.d., slovinsko - dimetyl-fumarát - 59 - immunopraeparata
dimethyl fumarate teva
teva gmbh - dimetylfumarát - multiple sclerosis, relapsing-remitting; multiple sclerosis - imunosupresíva - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
dimethyl fumarate accord
accord healthcare s.l.u. - dimetylfumarát - multiple sclerosis, relapsing-remitting; multiple sclerosis - imunosupresíva - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
arbicen 240 mg
egis pharmaceuticals plc, maďarsko - dimetyl-fumarát - 59 - immunopraeparata
arbicen 120 mg
egis pharmaceuticals plc, maďarsko - dimetyl-fumarát - 59 - immunopraeparata
dimtelzo 240 mg
sandoz d.d., slovinsko - dimetyl-fumarát - 59 - immunopraeparata
dimtelzo 120 mg
sandoz d.d., slovinsko - dimetyl-fumarát - 59 - immunopraeparata
nideolo 120 mg
pharmathen s.a., grécko - dimetyl-fumarát - 59 - immunopraeparata